Braves Struggle in Defeat to Red Sox, Highlighted by Critical Errors The Atlanta Braves suffered an 8-0 loss to the Boston Red Sox on Wednesday night at Fenway Park, marking their second consecutive series defeat and raising concerns about their defensive execution. The game’s turning point came in the fourth inning when a critical error by first baseman Matt Olson allowed Boston to score six runs, overshadowing the performance of starting pitcher Bryce Elder, who endured his first rough start of the season. Manager Walt Weiss acknowledged the team’s struggles, stating, “The game got away from us in the fourth inning. We didn’t really take care of the ball.” The Braves will need to secure a win in Thursday’s series finale to avoid a rare two-series losing streak. Elder, who entered the game with a 2.50 ERA and 13 consecutive starts allowing three earned runs or fewer, faced challenges in the fourth inning. With runners on second and third and one out, Olson failed to field a sharp grounder hit by Marcelo Mayer, allowing Masataka Yoshida to attempt a risky steal. Olson’s error, combined with subsequent singles to three consecutive batters, led to Elder being replaced by Dylan Dodd. Dodd allowed two inherited runners to score on a single by Wilyer Abreu, exacerbating the Braves’ deficit. Despite the outing, Elder’s season ERA remains sixth in the National League, and Weiss expressed confidence in the pitcher, noting, “That’s the first really tough one he’s had in a really long time.” The game’s outcome was further influenced by a defensive play in the first inning, where left fielder Mauricio Dubón threw out Ceddanne Rafaela at the plate, preventing a potential run.#atlanta_braves #boston_red_sox #walt_weiss #fenway_park #matt_olson
Braves-Royals Matchup: Injury Concerns and Playoff Hopes The Atlanta Braves enter the 2025 season with a mix of optimism and caution, as they aim to rebound from a 86-win campaign last year that marked their first losing season since 2017. Manager Walt Weiss faces challenges from the outset, with key players like catcher Sean Murphy, infielder Ha-Seong Kim, and pitchers Spencer Strider, Spencer Schwellenbach, and Joe Jiménez already sidelined. Despite these setbacks, PECOTA projects the team for 89 wins, highlighting their potential with a core of power hitters and reliable pitching. The Braves’ offense, which ranked middle of the pack in runs scored last season, showed improvement in the second half. Ronald Acuña Jr. and Austin Riley, both sidelined by injuries in 2024, are expected to contribute significantly. Matt Olson, who posted a 11th-place finish in National League fWAR and hit 29 home runs, remains a key offensive threat. Michael Harris II’s 20/20 season (20 homers, 20 steals) in 2024 further underscores the team’s depth. The roster also includes additions like Mike Yastrzemski, a former Royals outfielder who excelled in 2024. Yastrzemski will need to replace Marcell Ozuna, who moved to the Pirates, and Jurickson Profar, suspended for a year due to PED violations. Shortstop duties will fall to Mauricio Dubón, a slick-fielding player, while non-roster invitees Dominic Smith and Kyle Farmer bolster the lineup. On the pitching side, the Braves face significant injury concerns. Despite a 2024 Cy Young Award for Chris Sale, the staff has struggled with setbacks. Sale, 36, is healthy for Opening Day and has a strong history against the Royals, with a 2.66 ERA in 189.2 innings.#atlanta_braves #walt_weiss #sean_murphy #ha_seong_kim #spencer_strider
Jurickson Profar faces a 162-game suspension for performance-enhancing drugs after his appeal was denied, marking the end of his 2026 season with the Atlanta Braves. The decision comes as Major League Baseball confirmed Profar tested positive for exogenous testosterone and its metabolites, resulting in the full-season ban for a second violation. The suspension makes him the sixth player to receive such a penalty since MLB implemented the policy in 2014, which mandates a 162-game suspension for repeat offenders. Profar, 33, will forfeit his $15 million salary for 2026 and will be ineligible for postseason play. The suspension follows a prior 80-game ban in March 2025 after he tested positive for chorionic gonadotropin (hCG), a hormone linked to testosterone production. At the time, Profar issued a statement acknowledging his responsibility and accepting MLB’s decision, though he denied intentional wrongdoing. His 2025 suspension came early in the season, and after returning in July, he posted a .245/.353/.434 batting line with 14 home runs and 43 RBIs while playing left field. The Braves signed Profar to a three-year, $42 million contract in January 2025 after he had a standout season with the San Diego Padres. As an All-Star in 2024, Profar was expected to play a key role in Atlanta’s lineup, potentially as the No. 2 hitter behind Ronald Acuña Jr. However, his absence for the entire 2026 season will reshape the team’s plans. Braves first-year manager Walt Weiss noted the DH position will be “fairly fluid” without Profar, citing the addition of left fielder Mike Yastrzemski, who signed a $23 million, two-year deal in the offseason. Yastrzemski, along with Acuña and Michael Harris, is expected to form the starting outfield.#atlanta_braves #jurickson_profar #major_league_baseball #walt_weiss #mike_yastrzemski
